Mereo Biopharma Group Plc Overview

Mereo Biopharma Group Plc Other Income Expense Net

Other Income/Expense Net for MREO.

Quarterly Other Income/Expense

$1.95M

↑ 215.65% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

$304967.00

↓ 72.43% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin